Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Boehringer Ingelheim
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
Taiho Oncology, Inc.
NRG Oncology
Eli Lilly and Company
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Avistone Biotechnology Co., Ltd.
Checkpoint Therapeutics, Inc.
Novartis
EpicentRx, Inc.
Spanish Lung Cancer Group
Alliance for Clinical Trials in Oncology
RTOG Foundation, Inc.
UNICANCER
Fuzhou General Hospital
Canadian Cancer Trials Group
Incyte Corporation
SWOG Cancer Research Network
Alliance for Clinical Trials in Oncology
Yonsei University
Alliance for Clinical Trials in Oncology
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
University College, London
Jiangsu Simcere Pharmaceutical Co., Ltd.
Seoul National University Hospital
Merck KGaA, Darmstadt, Germany
Sanofi
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Radiation Therapy Oncology Group
Spectrum Pharmaceuticals, Inc